Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01171794 · ClinicalTrials.gov registry record · Phase 3
Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS)
A Phase 3 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 3
- Development phase
- 89
- Enrollment target
NCT01171794: Completed Phase 3 study, sponsored by Stanford University.
NCT01171794 is a Phase 3 study that has completed, run by Stanford University. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01171794, a Phase 3 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 89 participants
- Enrollment target
Study Summary
This is a research study on Altitude Illness. From the information collected and studied in this project we hope to learn more about Altitude Illness, including factors that may affect and prevent the development and progression of this condition. We hope to learn if the commonly used non-steroidal anti-inflammatory medication, ibuprofen can prevent altitude illness. Possible participants in this study are healthy adults who indicated they would like to participate, learn about altitude illness, and desire to hike Barcroft Peak. Stanford University researchers hope to enroll about 100 participants.
Interventions
- DRUG Placebo
- DRUG Ibuprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2010-07 |
| Est. Completion | 2010-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01171794
The ClinicalTrials.gov registry entry for NCT01171794 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01171794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01171794 about?
NCT01171794 is a clinical study titled "Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS)". This is a research study on Altitude Illness. From the information collected and studied in this project we hope to learn more about Altitude Illness, including factors that may affect and prevent the development and progression of this condition. We hope to learn if the commonly used non-steroidal ...
What is the current status of trial NCT01171794?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 89 participants. The study started on 2010-07. Estimated completion is 2010-08.
What interventions are being tested in trial NCT01171794?
The interventions under investigation include: Placebo (DRUG), Ibuprofen (DRUG).
Who is sponsoring clinical trial NCT01171794?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.